The Perfect Marriage of Curated Data + Specialized Large Language Model in Drug-GPT™ (Talking Medicines)
Healthcare marketers can now access vital insights about patients and healthcare professionals through the world’s first curated Patient Voice GPT, providing access to real-world insights about the lived experience, opinions, and sentiment of patients and HCPs.
Talking Medicines has created one of the first Large Language Models (LLMs) specifically designed for healthcare. Curated social data comes from a wide array of unstructured sources. Using artificial intelligence, machine learning, and natural language processing. Drug-GPT™ can classify signals into accurate structured intelligence.
The advent of ChatGPT provides many opportunities for the sector to embrace AI. With the launch of Drug-GPT™ in May 2023, Talking Medicines has shown that unstructured social signals from patients and HCPs can train healthcare language models, which can be used by healthcare advertising agencies for instant access to high-quality, clean social data intelligence.
Drug-GPT™ using Talking Medicines’ curated social data, allows subscribing agencies to secure instant and accurate insights. Customers can analyze uniquely curated voices with a classification accuracy of 95%. All insights are fully compliant with health sector regulations and backed by a suite of quality control processes.
Insights help agencies inform new business pitches, develop winning strategies, create creative content, and monitor the impact of critical market events on customer behavior. Subscribers can answer their own questions about how patients experience drugs and treatments—and how the HCP perspective may differ. The platform proved its efficacy during a successful launch with 100 top healthcare ad agencies.
